Home/Filings/3/0001209191-19-049958
3//SEC Filing

Haldor Topsoe Holding A/S 3

Accession 0001209191-19-049958

CIK 0001496323other

Filed

Sep 16, 8:00 PM ET

Accepted

Sep 17, 8:39 PM ET

Size

8.7 KB

Accession

0001209191-19-049958

Insider Transaction Report

Form 3
Period: 2019-09-17
Holdings
  • Series B Preferred Stock

    Exercise: $0.00Common Stock (9,039,453 underlying)
  • Series C Preferred Stock

    Exercise: $0.00Non-Voting Common Stock (2,269,838 underlying)
Footnotes (3)
  • [F1]The Series B Preferred Stock will automatically convert into shares of Common Stock on a 1-for-1 basis immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock does not have an expiration date.
  • [F2]All shares are held directly by Haldor Topsoe Holdings A/S (HTH). Mr. Jakob Haldor Topsoe, Ms. Christina Teng Topsoe, Mr. Martin Topsoe and Mr. Emil Oigaard, members of the board of directors of HTH, may be deemed to share voting and investment power with respect to the shares reported herein and disclaim beneficial ownership of such shares, except to the extent of his or her pecuniary interest therein, if any. Mr. Jakob Haldor Topsoe and Ms. Christina Teng Topsoe are members of the Issuer's board of directors.
  • [F3]The Series C Preferred Stock will automatically convert into shares of Non-Voting Common Stock on a 1-for-1 basis, pursuant to an election made by the Reporting Person, immediately prior to the closing of the Issuer's initial public offering, and has no expiration date. Each share of Non-Voting Common Stock is convertible at any time at the option of the Reporting Person into one share of Common Stock (subject to a 4.99% beneficial ownership limitation that may be increased or decreased by the Reporting Person) and has no expiration date.

Issuer

IGM Biosciences, Inc.

CIK 0001496323

Entity typeother
IncorporatedDenmark

Related Parties

1
  • filerCIK 0001788357

Filing Metadata

Form type
3
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 8:39 PM ET
Size
8.7 KB